StockWatch
·
MOTHERSON · Q2 FY27 · THE VERDICT

Record Growth Can't Hide the Margin Squeeze

Motherson hit ₹38,280 Crore in revenue (up 27% YoY) and a record USD 106 billion order book, but EBITDA margins compressed 80 basis points. The quarter shows growth—and execution risk.

Q2 FY27 resultsMOTHERSONSamvardhana Motherson International Ltd13 Nov 2026 · 6 min read
Reported PAT

₹1,218 Cr

+44% YoY

Adjusted PAT

~₹1,175 Cr

ex ₹43 Cr forex/one-time · +37% YoY

EBITDA margin

8.8%

−80 bps YoY from 9%

Order book

USD 106B

record; strong forward demand

The headline screams growth—₹38,280 Crore revenue, up 27% year-on-year, with a record order book of USD 106 billion. But the quarter's real story is hidden below the surface: EBITDA margins fell 80 basis points to 8.8% despite that growth. For a management that just integrated three mid-sized acquisitions (Autoelectric, Yutaka Giken, Nexans), the margin squeeze is both expected and concerning. Expected because integration costs are real. Concerning because there is no clear line of sight to when margins recover.

Where the profit landed

Reported PAT of ₹1,218 Crore looks stellar at +44% YoY. But management disclosed that roughly ₹43 Crore of that came from forex gains and one-time items. Strip those out, and normalized PAT sits at around ₹1,175 Crore—still up 37% YoY, but a more honest picture of organic profitability. The gap is small (3.6% of reported), but in an earnings call where management is vague on margin recovery, every crore counts.

Q2 FY27 PAT, ₹ Crore
0454.72909.441,364.161,218Reported43Forex/one-time1,175Adjusted
Reported profit includes ~₹43 Cr of non-recurring items. Adjusted profit is the apples-to-apples organic run-rate.

The margin trap

Revenue grew 27%, but EBITDA margin fell 80 bps to 8.8% (from 9% a year ago). In normal circumstances, revenue growth of that scale should hold margins flat or improve them—fixed costs are spread over more sales. Instead, margins compressed. Why? Autoelectric and Yutaka Giken, both acquired in the past year, are dragging profitability as they integrate. Yutaka is currently at 'shade lighter' margins than the group average, and Autoelectric is still early in its integration curve. Management blames commodity cost inflation (copper, aluminium, plastics) and incomplete pass-throughs to customers, but the core issue is that the acquisitions were accretive to growth and dilutive to margins—exactly what integration headwinds look like.

EBITDA margin stood at 8.8% compared with 9% in Q2 FY 2026, representing a contraction of approximately 80 basis points due to acquisition integration.

Management claims vs. what holds up

Grading the call's key assertions against reported data

Q2 revenue ₹38,280 Cr, growth 27% YoY

What the data says

₹38,279.8 Cr delivered; YoY 26.9%—rounding explained the 27% figure

Verdict

Supported

EBITDA margin 8.8%, down 80 bps from prior-year 9%

What the data says

Exact match to OPM 8.8%; compression confirmed and attributed to acquisition integration

Verdict

Supported

Normalized PAT ₹1,175 Cr, up 37% YoY

What the data says

Reported PAT ₹1,217.6 Cr (+44% YoY), outpacing normalized by ~₹43 Cr from forex/one-time gains

Verdict

Supported (with caveat on sustainability)

GF-3 consumer electronics plant launching Q4 FY27, on track

What the data says

Prior guidance from H1 FY27 call said Q3 FY27 launch. Now pushed to Q4—one quarter slip acknowledged

Verdict

Overstated (timing miss acknowledged)

Autoelectric & Yutaka added USD 2 billion annualized revenue capacity

What the data says

Autoelectric consolidated full Q2; Yutaka for two months. Margin drag persists; no detailed segment revenue disclosed

Verdict

Unverified (capacity claimed but profitability story unclear)

What changed on this call

Shifts from prior quarter guidance
  • GF-3 launch timing: Q3 FY27 → Q4 FY27

  • Capex guidance ₹6,000 Cr ±10% maintained; H1 ₹3,585 Cr on track (59.75% of full-year)

  • Emerging markets capex emphasis increased: 60% of FY27 earmarked for India, SE Asia

  • Wiring harness growth accelerated to 68% YoY (drivers: North America CV +43.6%, India +18.9%)

The bull-bear ledger

For the bull case: Record order book of USD 106 billion is a genuine demand signal. Revenue growth of 27% in a period when global light vehicle production fell 2.3% shows market share wins and emerging markets resilience (India +15% overall, +18.9% in commercial vehicles). Capex is on track (H1 ₹3,585 Cr = 59.75% of FY27 guidance), and emerging businesses (medical devices, aerospace, humanoid robotics) are gaining traction. The company has deployed 940+ automation projects and targets >1,000 by next year—automation gains should drive margin recovery as integration winds down. FII ownership ticking up (+0.42pp QoQ to 12.87%) suggests international confidence.

For the bear case: Margin compression of 80 bps despite 27% revenue growth is a red flag. Historically, strong growth companies expand margins; here, they contracted. That is a quality-of-earnings concern. GF-3 (the largest consumer electronics facility) already slipped from Q3 to Q4—if it slips again, the payback timeline extends and H2 profit is deferred. Autoelectric and Yutaka are margin-dilutive in their integration phase; management promised recovery by end-FY27 but offered no specific targets or timelines. Global automotive is slowing (LVP −2.3%, China −5.5%, North America −3.8%). Commodity cost inflation is squeezing margins, and customer pass-throughs are incomplete and uncertain in timing. The stock is trading 4.87% below its all-time high, pricing in a successful recovery—limited upside margin for error.

The honest read: Motherson is a quality story with genuine emerging markets tailwinds and a strategic diversification into non-auto businesses. Order book and revenue growth are real. But this quarter shows execution risk: margins are weaker than the growth rate suggests, GF-3 is slipping, and acquisition integration is taking longer than hoped. The stock is trading near all-time highs, pricing in a successful recovery. Upside depends on three things materializing: (1) margins recovering to ≥9.1% in H2 FY27 as acquisitions integrate and automation drives productivity, (2) GF-3 not slipping further and ramping profitably post-launch, and (3) global automotive stabilizing. If any of these falters, the margin recovery narrative collapses and earnings growth stalls. A Hold rating is warranted—good company, execution questions, limited upside from current levels.

How the market sees it

The stock is trading at ₹164.8, within 4.87% of its all-time high of ₹173.23 and well above its 52-week low of ₹101.08 (up 63% off that low). It is trading above its 20-day, 50-day, and 200-day moving averages—a bullish technical setup. RSI sits at 54.9 (neutral, not overbought). Volume trend is normal. Foreign institutional investors (FIIs) hold 12.87%, up 0.42 percentage points from the prior quarter—they are still accumulating despite the rally. Domestic institutions (DIIs) hold 20.65%, down 0.48pp. Promoters remain stable at 48.60%. The FII uptick is consistent with the bull thesis—a quality story with emerging market tailwinds resonating with global allocators. However, the stock's proximity to ATH and +63% gain off the low suggests much of the bull case is already priced in.

Risks, ranked by severity for a holder

What should concern an investor holding this stock today, ordered by impact

Margin recovery execution—EBITDA fell 80 bps despite 27% growth; management promises recovery by end-FY27 but no specific targets disclosed

HIGH

If margins stay compressed at 8.8% through H2 FY27, the reported profit growth of 37-44% is a mirage. Earnings multiple would re-rate lower. This is the pivotal risk.

GF-3 consumer electronics facility timing—already slipped Q3→Q4 FY27; further delays would defer profit contribution and reduce capex payback ROI

HIGH

GF-3 is the centerpiece of non-auto diversification. Another slip would signal execution risk and compress near-term returns on ₹7,500 Cr capex across three consumer electronics plants.

Global automotive production slowdown—LVP down 2.3% YoY; China −5.5%, North America −3.8%; legacy OEM customers cutting production

MEDIUM

Automotive is still the core business. While India +15% helps, global deterioration could force capex reallocation and slow growth. Pricing power erodes as customers consolidate.

Acquisition integration profitability—Autoelectric, Yutaka, Nexans currently margin-dilutive; if synergies don't materialize by end-FY27, margin recovery stalls

MEDIUM

The acquisitions were accretive to revenue but dilutive to EBITDA. They represent USD 2 billion in annualized capacity, but profitability uplift is promised, not proven. Yutaka noted as lighter-margin; no timeline for inflection.

Commodity cost inflation and incomplete pass-throughs—copper, aluminium, polymers driving input costs; OEM pass-throughs vary by contract and location

MEDIUM

Commodity volatility is cyclical and structural for auto suppliers. If prices remain elevated, pass-throughs may lag input inflation, keeping margins depressed.

What to watch next

Three concrete questions to resolve the debate
  • 1 · H2 FY27 EBITDA margin trend (Q3 and Q4 results)

    Margins need to improve sequentially to ≥9.1% to validate management's recovery thesis. If Q3 stays at 8.8% or deteriorates, margin recovery is in doubt and the stock re-rates lower.

  • 2 · GF-3 commercial production launch (expected Q4 FY27) and early ramp trajectory

    Watch for any further delays or production constraints. Early revenue contribution from GF-3 is the second-most important validation of management credibility.

  • 3 · Investor day & Vision 2030 plan (promised next calendar year)

    Management has deflected on specific margin and profitability targets. The investor day is where management must quantify margin recovery, emerging business ramp-up, and multi-year ROI on capex.

Motherson is executing on emerging markets and non-auto diversification. Order book, revenue growth, and India momentum are real. But this quarter shows execution risk: margins are weaker than the growth rate suggests, GF-3 is slipping, and acquisition integration is taking longer than hoped. The stock is trading near all-time highs, pricing in a successful recovery. The single number to track from here is EBITDA margin in Q3 and Q4 FY27. If it reaches ≥9.2%, the bull case holds. If it stays at 8.8%, the margin recovery narrative collapses and the stock deserves a lower multiple. Verdict: Hold at ₹164.8. Good company, execution questions, limited upside from current levels.

Informational and educational content only. Not investment advice.